Simpex pharma Pvt. Ltd. specializes in manufacturing
of pharmaceutical products. Simpex started its operation as an Export
House. With its focused approach in Pharmaceutical Market and quest for
constant research and development, Simpex today has evolved itself as an
organization having manufacturing plant, which complies with the
maximum norms set by World Regulatory Boards. Simpex has well
established operations in Countries like Russia, Ukraine, Kazakhstan,
Belarus, Uzbekistan, French African Countries, ASEAN, Sri Lanka, India
etc.
Simpex has its distribution and marketing agreement with Global Exim
FZC for the promotion and distribution of its products in the
territories like U.A.E., Russia and other CIS countries.
Simpex has decided to outsource pharmacovigilance activities and has
delegated the set-up and maintenance of the global and local PV system
to a service provider-PharmaLex India Pvt. Ltd. (PharmaLex). PharmaLex
also provides Simpex with compilation and maintenance of the
Pharmacovigilance System Master File (PSMF). Pharmacovigilance
activities will be carried out at PharmaLex office in New Delhi, India.
All communication (e.g. correspondence, safety data and document
exchange) between service providers and Simpex will be in English
language.
Marketing Authorization Holder (MAH) and Qualified Person Responsible
for Pharmacovigilance (QPPV) ensure PharmaLex is provided with current
and valid information needed for performing of PV activities and meeting
regulatory timelines and requirements as PharmaLex’ operational site is
in India.
This PSMF provides a description of the PV system for the medicinal
products as per pharmacovigilance norms and requirements form various
regulatory bodies.